Rapid7 grants 525,000 RSUs to new Chief Product and Technology Officer
Rapid7, Inc. granted 525,000 RSUs to new Chief Product and Technology Officer Dejan Deklich as an employment inducement. The award, approved by the independent Compensation Committee under Nasdaq Rule 5635(c)(4), vests over three years subject to continued service.
*this image is generated using AI for illustrative purposes only.
Rapid7, Inc. granted an inducement award of 525,000 restricted stock units (RSUs) to Dejan Deklich, its newly appointed Chief Product and Technology Officer, on June 15, 2026. The grant was made under Rapid7's 2015 Equity Incentive Plan as a material inducement for Mr. Deklich to commence employment with the company. The award was unanimously approved by Rapid7's Compensation Committee, which is independent within the meaning of Nasdaq Listing Rule 5605(a)(2), in accordance with Nasdaq Listing Rule 5635(c)(4).
The RSUs vest over a three-year period from the vesting commencement date. One-third of the RSUs will vest on the first anniversary, with the remaining two-thirds vesting in equal quarterly installments through the third anniversary. Vesting is contingent upon Mr. Deklich's continued employment with Rapid7 through each applicable vesting date.
Award Details
| Component | Details |
|---|---|
| Recipient | Dejan Deklich, Chief Product and Technology Officer |
| Grant Date | June 15, 2026 |
| Total RSUs Granted | 525,000 |
| Vesting Schedule | 3 years |
| Regulatory Basis | Nasdaq Listing Rule 5635(c)(4) |
The grant was issued pursuant to the inducement award share pool of Rapid7's 2015 Equity Incentive Plan, as amended. Rapid7, Inc. (NASDAQ: RPD) is a global leader in AI-powered managed cybersecurity operations.
How will Dejan Deklich's appointment influence Rapid7's product roadmap and AI-driven cybersecurity capabilities?
What does this significant equity grant suggest about Rapid7's retention strategy for key executive talent?
How might the vesting schedule align with Rapid7's long-term strategic goals and performance milestones?
19
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
